DE10399015I2 - Stabilisierte pharmazeutische formulierung, die wachstumshormon und histidin enthält - Google Patents

Stabilisierte pharmazeutische formulierung, die wachstumshormon und histidin enthält

Info

Publication number
DE10399015I2
DE10399015I2 DE10399015C DE10399015C DE10399015I2 DE 10399015 I2 DE10399015 I2 DE 10399015I2 DE 10399015 C DE10399015 C DE 10399015C DE 10399015 C DE10399015 C DE 10399015C DE 10399015 I2 DE10399015 I2 DE 10399015I2
Authority
DE
Germany
Prior art keywords
histidine
growth hormone
pharmaceutical formulation
formulation containing
containing growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE10399015C
Other languages
English (en)
Other versions
DE10399015I1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK204691A external-priority patent/DK204691D0/da
Priority claimed from DK136492A external-priority patent/DK136492D0/da
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of DE10399015I2 publication Critical patent/DE10399015I2/de
Application granted granted Critical
Publication of DE10399015I1 publication Critical patent/DE10399015I1/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE10399015C 1991-12-20 1992-12-16 Stabilisierte pharmazeutische formulierung, die wachstumshormon und histidin enthält Granted DE10399015I1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK204691A DK204691D0 (da) 1991-12-20 1991-12-20 Hidtil ukendt farmaceutisk praeparat
DK136492A DK136492D0 (da) 1992-11-10 1992-11-10 A pharmaceutical formulation
PCT/DK1992/000379 WO1993012812A1 (en) 1991-12-20 1992-12-16 A stabilized pharmaceutical formulation comprising growth hormone and histidine

Publications (2)

Publication Number Publication Date
DE10399015I2 true DE10399015I2 (de) 2008-08-07
DE10399015I1 DE10399015I1 (de) 2012-05-03

Family

ID=26065653

Family Applications (3)

Application Number Title Priority Date Filing Date
DE10399015C Granted DE10399015I1 (de) 1991-12-20 1992-12-16 Stabilisierte pharmazeutische formulierung, die wachstumshormon und histidin enthält
DE69233704T Expired - Lifetime DE69233704T2 (de) 1991-12-20 1992-12-16 Stabilisierte pharmazeutische Formulierung, umfassend Wachstumshormon und Histidin
DE69232847T Expired - Lifetime DE69232847T2 (de) 1991-12-20 1992-12-16 Stabilisierte pharmazeutische formulierung, die wachstumshormon und histidin enthält

Family Applications After (2)

Application Number Title Priority Date Filing Date
DE69233704T Expired - Lifetime DE69233704T2 (de) 1991-12-20 1992-12-16 Stabilisierte pharmazeutische Formulierung, umfassend Wachstumshormon und Histidin
DE69232847T Expired - Lifetime DE69232847T2 (de) 1991-12-20 1992-12-16 Stabilisierte pharmazeutische formulierung, die wachstumshormon und histidin enthält

Country Status (24)

Country Link
EP (2) EP1197222B1 (de)
JP (2) JP2950617B2 (de)
KR (1) KR100266502B1 (de)
AT (2) ATE227583T1 (de)
AU (1) AU667503B2 (de)
BG (1) BG63075B1 (de)
CA (1) CA2125855C (de)
CZ (1) CZ283361B6 (de)
DE (3) DE10399015I1 (de)
DK (1) DK0618807T3 (de)
ES (2) ES2185625T3 (de)
FI (1) FI115116B (de)
HU (1) HUT69402A (de)
IL (1) IL104152A (de)
MX (1) MX9207374A (de)
NL (1) NL300126I1 (de)
NO (1) NO942300L (de)
NZ (1) NZ246556A (de)
PT (1) PT618807E (de)
RO (1) RO111990B1 (de)
RU (1) RU2122426C1 (de)
SK (1) SK279641B6 (de)
UA (1) UA41502C2 (de)
WO (1) WO1993012812A1 (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849704A (en) * 1991-12-20 1998-12-15 Novo Nordisk A/S Pharmaceutical formulation
US5849700A (en) * 1991-12-20 1998-12-15 Novo Nordisk A/S Pharmaceutical formulation
DK204791D0 (da) * 1991-12-20 1991-12-20 Novo Nordisk As Hidtil ukendt farmaceutisk praeparat
US6022858A (en) * 1991-12-20 2000-02-08 Novo Nordisk A/S Pharmaceutical formulation of human-growth hormone pretreated with zinc salt
US6288030B1 (en) * 1993-12-22 2001-09-11 Amgen Inc. Stem cell factor formulations and methods
EP0804223B1 (de) * 1994-06-17 1999-09-22 Applied Research Systems ARS Holdings N.V. Hgh enthaltende pharmazeutische zubereitungen
TW426737B (en) * 1994-06-27 2001-03-21 Hayashibara Biochem Lab Saccharide composition with reduced reducibility, and preparation and uses thereof
US5654278A (en) * 1994-10-13 1997-08-05 Novo Nordisk A/S Composition and method comprising growth hormone and leucine
US5631225A (en) * 1994-10-13 1997-05-20 Novo Nordisk A/S Pharmaceutical formulation
IL115592A (en) * 1994-10-13 2000-07-26 Novo Nordisk As Stabilized pharmaceutical formulation comprising a growth hormone and leucine
US5547696A (en) * 1994-10-13 1996-08-20 Novo Nordisk A/S Pharmaceutical formulation
ZA96122B (en) * 1995-01-13 1996-07-24 Novo Nordisk As A pharmaceutical formulation
US5705482A (en) * 1995-01-13 1998-01-06 Novo Nordisk A/S Pharmaceutical formulation
JPH10511964A (ja) * 1995-01-13 1998-11-17 ノボ ノルディスク アクティーゼルスカブ 成長ホルモン及びＸ−Ｌｙｓを含む安定化医薬製剤
US5552385A (en) * 1995-06-05 1996-09-03 Novo Nordisk A/S Pharmaceutical formulation
US6936289B2 (en) 1995-06-07 2005-08-30 Danisco A/S Method of improving the properties of a flour dough, a flour dough improving composition and improved food products
ZA965367B (en) * 1995-07-12 1997-01-23 Novo Nordisk As A pharmaceutical formulation
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
KR100236393B1 (ko) * 1996-02-02 1999-12-15 나까니시 히로유끼 사람성장호르몬을 함유하는 의약제제
US20070179096A1 (en) 1996-04-24 2007-08-02 Novo Nordisk A/S Pharmaceutical Formulation
US20020077461A1 (en) * 1996-04-24 2002-06-20 Soren Bjorn Pharmaceutical formulation
ES2230727T3 (es) * 1997-11-12 2005-05-01 Alza Corporation Procedimiento de administracion dermal de polipeptidos.
EP2311436A1 (de) * 1998-04-27 2011-04-20 Altus Pharmaceuticals Inc. Stabilisierte Protein-Kristalle, diese enthaltende Formulierungen und ihre Herstellungsverfahren
AU2001238540A1 (en) * 2000-02-24 2001-09-03 Monsanto Technology Llc Non-aqueous injectable formulations for extended release of somatotropin
US6719992B2 (en) 2000-06-26 2004-04-13 Monsanto Technology Llc Non-aqueous surfactant-containing formulations for extended release of somatotropin
US6664234B1 (en) 2000-06-30 2003-12-16 Monsanto Technology Llc Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin
MXPA03001092A (es) 2000-08-07 2003-09-25 Nektar Therapeutics Al Corp Polvos de proteina de haz de 4 helices secados por rocio, inhalables, que tienen agregacion minimizada.
JP5485489B2 (ja) 2000-08-11 2014-05-07 中外製薬株式会社 抗体含有安定化製剤
MXPA03010511A (es) 2001-05-18 2004-03-02 Danisco Metodo para preparar una masa con una enzima.
EP2460530A3 (de) 2002-12-31 2012-08-29 Althea Technologies, Inc. Kristalle des menschlichen Wachstumshormons und Verfahren zu ihrer Herstellung
ZA200505306B (en) * 2002-12-31 2006-09-27 Altus Pharmaceuticals Inc Complexes of protein crystals and ionic polymers
PL2107069T3 (pl) 2003-08-05 2013-06-28 Novo Nordisk As Nowe pochodne insuliny
PL1791933T3 (pl) 2004-07-16 2011-12-30 Dupont Nutrition Biosci Aps Sposób enzymatycznego odgumowania oleju
NZ555503A (en) * 2004-12-15 2010-01-29 Biovitrum Ab Publ Therapeutic formulations of keratinocyte growth factor
US7816320B2 (en) * 2004-12-22 2010-10-19 Ambrx, Inc. Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35
CN101268098A (zh) * 2005-08-30 2008-09-17 诺沃-诺迪斯克保健股份有限公司 聚乙二醇化生长激素的液体制剂
WO2007033427A1 (en) * 2005-09-23 2007-03-29 Metabolic Pharmaceuticals Limited Stabilisation of peptides with basic amino acids
DK1969004T3 (da) 2005-12-28 2011-11-28 Novo Nordisk As Insulinsammensætninger og metode til at lave en sammensætning
BRPI0713963A2 (pt) 2006-07-07 2012-11-27 Novo Nordisk Healthcare Ag conjugados de proteìna e métodos para sua preparação
AU2007333959A1 (en) * 2006-12-18 2008-06-26 Altus Pharmaceuticals Inc. Human growth hormone formulations
WO2008152106A1 (en) 2007-06-13 2008-12-18 Novo Nordisk A/S Pharmaceutical formulation comprising an insulin derivative
AU2009309623B9 (en) 2008-10-30 2014-10-02 Novo Nordisk A/S Treating diabetes melitus using insulin injections with less than daily injection frequency
CN103432566A (zh) * 2008-12-16 2013-12-11 建新公司 寡糖-蛋白缀合物
WO2010096394A2 (en) 2009-02-17 2010-08-26 Redwood Biosciences, Inc. Aldehyde-tagged protein-based drug carriers and methods of use
KR20120123365A (ko) 2009-12-21 2012-11-08 암브룩스, 인코포레이티드 변형된 돼지 소마토트로핀 폴리펩티드 및 이의 용도
CA2784793A1 (en) 2009-12-21 2011-07-21 Ambrx, Inc. Modified bovine somatotropin polypeptides and their uses
CN103119056B (zh) * 2010-09-21 2015-11-25 辉凌公司 用于制备重组人生长激素的改良方法
RU2013123515A (ru) 2010-10-27 2014-12-10 Ново Нордиск А/С Лечение сахарного диабета с помощью инъекций инсулина, вводимых с различными интервалами
WO2012097333A2 (en) 2011-01-14 2012-07-19 Redwood Bioscience, Inc. Aldehyde-tagged immunoglobulin polypeptides and method of use thereof
NZ703341A (en) 2012-06-05 2016-11-25 Neuroderm Ltd Compositions comprising apomorphine and organic acids and uses thereof
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
US10137172B2 (en) 2013-04-30 2018-11-27 Novo Nordisk A/S Administration regime
US11559580B1 (en) * 2013-09-17 2023-01-24 Blaze Bioscience, Inc. Tissue-homing peptide conjugates and methods of use thereof
US10702606B2 (en) 2015-12-10 2020-07-07 Menicon Co., Ltd. Peptide composition
AU2017257504A1 (en) 2016-04-26 2018-10-25 R.P. Scherer Technologies, Llc Antibody conjugates and methods of making and using the same
EP3801605A4 (de) * 2018-05-25 2022-03-16 Dr. Reddy's Laboratories Ltd. Stabile fusionsproteinformulierung
WO2020004368A1 (ja) * 2018-06-25 2020-01-02 Ｊｃｒファーマ株式会社 蛋白質含有水性液剤
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
HUE062893T2 (hu) 2018-10-26 2023-12-28 Novo Nordisk As Stabil szemaglutid kompozíciók, és alkalmazásaik
WO2022197963A1 (en) * 2021-03-19 2022-09-22 Pfizer Inc. Long-acting growth hormone compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
US4917685A (en) * 1986-05-16 1990-04-17 International Minerals & Chem. Corp. Delivery device for the administration of stabilized growth promoting hormones
EP0374120A3 (de) * 1988-12-13 1991-07-31 Monsanto Company Zusammensetzung mit kontrollierter Wirkstoffabgabe von Polypeptiden
DK168790D0 (de) * 1990-07-13 1990-07-13 Novo Nordisk As

Also Published As

Publication number Publication date
FI115116B (fi) 2005-03-15
WO1993012812A1 (en) 1993-07-08
NL300126I1 (nl) 2003-07-01
CZ150794A3 (en) 1995-01-18
IL104152A0 (en) 1993-05-13
EP1197222B1 (de) 2007-08-01
ES2185625T3 (es) 2003-05-01
SK75494A3 (en) 1995-03-08
UA41502C2 (uk) 2001-09-17
KR100266502B1 (ko) 2000-09-15
NO942300D0 (no) 1994-06-17
ES2291264T3 (es) 2008-03-01
EP0618807B1 (de) 2002-11-13
ATE368472T1 (de) 2007-08-15
SK279641B6 (sk) 1999-01-11
NO942300L (no) 1994-08-19
DE69232847T2 (de) 2003-09-11
CZ283361B6 (cs) 1998-03-18
DE69233704T2 (de) 2008-05-21
BG98806A (bg) 1995-02-28
RU2122426C1 (ru) 1998-11-27
RO111990B1 (ro) 1997-04-30
AU667503B2 (en) 1996-03-28
IL104152A (en) 1998-06-15
DE10399015I1 (de) 2012-05-03
DK0618807T3 (da) 2003-03-03
JP2950617B2 (ja) 1999-09-20
EP0618807A1 (de) 1994-10-12
ATE227583T1 (de) 2002-11-15
FI942906A (fi) 1994-06-17
AU3344693A (en) 1993-07-28
CA2125855C (en) 2008-05-13
MX9207374A (es) 1993-07-01
HU9401832D0 (en) 1994-09-28
CA2125855A1 (en) 1993-07-08
JPH11315031A (ja) 1999-11-16
HUT69402A (en) 1995-09-28
FI942906A0 (fi) 1994-06-17
NZ246556A (en) 1996-03-26
EP1197222A2 (de) 2002-04-17
DE69232847D1 (de) 2002-12-19
JPH07502516A (ja) 1995-03-16
RU94045932A (ru) 1997-04-20
PT618807E (pt) 2003-03-31
DE69233704D1 (de) 2007-09-13
BG63075B1 (bg) 2001-03-30
EP1197222A3 (de) 2004-02-04

Similar Documents

Publication Publication Date Title
DE10399015I2 (de) Stabilisierte pharmazeutische formulierung, die wachstumshormon und histidin enthält
DE69228704D1 (de) Stabilisierte pharmazeutische formulierung, die wachstumshormon und asparagin enthält
ATE119044T1 (de) Niedrig schmelzbarer, giessbarer arzneimittel- excipient und seine verwendung im zusammenhang mit pharmazeutischen zusammensetzungen.
CA2037884A1 (en) Stabilized gonadotropin containing preparations
ES2173197T3 (es) Una formula farmaceutica que contiene hormona de crecimiento e isoleucina.
DE69524965D1 (de) Wachstumshormon und valin enthaltende arzneimittel
HUP9603489A2 (hu) Gyógyszerkészítmény és eljárás előállítására
IL115592A (en) Stabilized pharmaceutical formulation comprising a growth hormone and leucine
HUP9802286A2 (hu) Stabilizált gyógyszerkészítmény amely valamely növekedési hormont és legalább egy bázikus aminosavmaradékot és legalább egy savas aminosav maradékot tartalmazó peptidet foglal magában